Report Content
Chapter 1 Methodology
1.1 Methodology & Scope
1.2 Market definition
1.3 Base estimates & calculations
1.4 Forecast parameters
1.5 COVID-19 impact analysis at global level
1.6 Data validation
1.7 Data Sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Public sources
Chapter 2 Executive Summary
2.1 Gene synthesis industry 360º synopsis, 2018 – 2032
2.2 Business trends
2.3 Regional trends
2.4 Method trends
2.5 Services trends
2.6 Application trends
2.7 End-use trends
Chapter 3 Gene Synthesis Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rapid advancements in the DNA synthesis technology
3.2.1.2 Growing investments in gene synthesis projects & synthetic biology R&D
3.2.1.3 Increased prevalence of genetic disorders and chronic disease
3.2.1.4 Rising adoption of the gene therapy
3.2.2 Industry pitfalls & challenges
3.2.2.1 Lack of skilled professionals
3.2.2.2 Complex gene synthesis techniques and high process cost
3.3 Growth potential analysis
3.3.1 By method type
3.3.2 By services type
3.3.3 By application
3.3.4 By end-use
3.4 COVID- 19 impact analysis
3.5 Technological advancements
3.6 Regulatory landscape
3.6.1 U.S.
3.6.2 Europe
3.7 Pricing analysis
3.8 Application potential
3.9 Porter's analysis
3.10 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
4.6 Strategic outlook matrix
Chapter 5 Gene Synthesis Market Size and Forecast, By Method (USD Million)
5.1 Key trends, by method
5.2 Solid-phase Synthesis
5.3 PCR-based Enzyme Synthesis
5.4 Chip-based Synthesis
Chapter 6 Gene Synthesis Market Size and Forecast, By Services (USD Million)
6.1 Key trends, by services
6.2 Antibody DNA Synthesis
6.3 Viral DNA Synthesis
6.4 Others
Chapter 7 Gene Synthesis Market Size and Forecast, By Application (USD Million)
7.1 Key trends, by application
7.2 Gene & Cell Therapy Development
7.3 Disease Diagnosis
7.4 Vaccine Development
7.5 Others
Chapter 8 Gene Synthesis Market Size and Forecast, By End-use (USD Million)
8.1 Key trends, by end-use
8.2 Academic and Research Institutes
8.3 Biopharmaceutical Companies
8.4 Contract Research Organizations
Chapter 9 Gene Synthesis Market Size and Forecast, By Region (USD Million)
9.1 Key trends, by region
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Poland
9.3.7 Sweden
9.3.8 The Netherlands
9.3.9 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Indonesia
9.4.7 Philippines
9.4.8 Malaysia
9.4.9 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Columbia
9.5.5 Chile
9.5.6 Peru
9.5.7 Rest of Latin America
9.6 MEA
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
9.6.4 Israel
9.6.5 Turkey
9.6.6 Iran
9.6.7 Rest of MEA
Chapter 10 Company Profiles
10.1 Thermo Fisher Scientific, Inc.
10.2 GenScript
10.3 Eurofins Genomics
10.4 ProMab Biotechnologies, Inc
10.5 Brooks Automation, Inc (GENEWIZ)
10.6 Twist Bioscience Corporation
10.7 Biomatik Corporation
10.8 Danaher Corporation
10.9 Bio Basic Inc.
10.10 Synbio Technologies
10.11 OriGene Technologies, Inc.
